Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Pre-Surgery diet could shrink liver and boost safety for obesity patients

NCT ID NCT04942093

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looks at whether a 4-week low-calorie, high-protein diet before bariatric surgery is safe and well-tolerated. Researchers want to see if it reduces liver fat and helps surgeons operate more easily. About 200 people with severe obesity will be split into two groups: one follows the diet, the other does not. The main focus is on side effects like low blood counts, vitamin deficiency, or muscle weakness.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
low-calorie, high-protein diet
What this could lead to
If successful, this diet could become a standard short-term preparation before obesity surgery, making the procedure safer and easier for surgeons.
What could go wrong
This is a small, early-stage study focused on safety and tolerance, not on long-term weight loss. The diet may cause side effects like low blood counts or muscle weakness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2023

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient eligible for bariatric surgery (according to HAS criteria) whose sleeve gastrectomy is scheduled * Patient with morbid obesity (BMI ≥ 40) * Age ≥ 18 years and ≤ 65 years * Haemoglobinemia ≥ 12 g/dL in men and ≥ 11 g/dL in women * Patient speaking and understanding French * Adult having read and understood the information letter and signed the consent form * Woman of childbearing age with effective / very effective contraception (Cf. CTFG) (estrogen-progestin or intrauterine device or tubal ligation) prior to surgery and a negative -HCG blood pregnancy test at inclusion, for the duration of the study * Postmenopausal woman: confirmatory diagnosis (non-medically induced amenorrhoea for at least 12 months prior to the inclusion visit) * Patient affiliated with, or beneficiary of a social security (health insurance) category Exclusion Criteria: * Contraindication to bariatric surgery detected during the preoperative assessment * Medical contraindication to a restrictive diet * Type I or II insulin-requiring diabetes * Severe renal insufficiency defined by a blood filtration rate \< 30 mL/min * Person wearing a pacemaker or any other implant with the same functions (cochlear implant, bladder battery, etc.) * Person deprived of liberty by an administrative or judicial decision or person placed under judicial protection / sub-guardianship or curatorship * A history of illness or psychological or sensory abnormality likely to prevent the subject from fully understanding the conditions required for participation in the protocol or to prevent him/her from giving informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bariatric surgery candidate are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Obesity, Abdominal

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHU de ROUEN

    RECRUITING

    Rouen, 76 000, France

  • Ch Dieppe

    RECRUITING

    Dieppe, France

  • HPE

    RECRUITING

    Le Havre, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.